The precautions used pre-emptively were close monitoring in intensive care unit (ICU) and high dependency unit (H DU), IV fluid hydration (3000ml/m 2/24hours), prophylactic allopurinol in a dose of 300mg/m2/day in three divided doses, restricted intake and output monitoring, preventing hyperkalaemia and
hyperphosphataemia. Urinary alkalinisation was avoided.
Possible risk factors affecting sleep quality in ESKD patients have been extensively reviewed, and the common factors reported include: male gender, advanced age, presence of RLS, high caffeine intake, alcohol, cigarette smoking,
hyperphosphataemia, anaemia, low plasma albumin concentration and inadequate dialysis (Al-Hahdali, 2012; Al-Jahdali, 2011; Chu et al., 2018; Gusbeth-Tatomir et al., 2007).
Goodman, "Importance of
hyperphosphataemia in the cardio-renal axis," Nephrology Dialysis Transplantation , vol.
The indication for surgical intervention are PTH level > 800pg/mL, hypercalcemia,
hyperphosphataemia, hypercalciuria, and severe symptom of hyperparathyroidism including unbearable bone pain, osteoporosis/osteopenia, and severe pruritus [11, 12].
Against this diagnosis, our patient presented with marked
hyperphosphataemia (4.95mmol/L) and hypermagnesaemia (1.25mmol/L) which is inconsistent with the electrolyte derangement that are the hallmarks of refeeding syndrome [12,13].
Effectiveness of a nurse-led educational programme on chronic kidney failure patients with
hyperphosphataemia: Randomised controlled trial.
*
Hyperphosphataemia, hypocalcaemia, hypercalcaemia, elevated calcium-phosphate product (CaXP) and elevated ALP.
Management of
hyperphosphataemia: Practices and perspectives amongst the renal care community.
Sevelamer for
hyperphosphataemia in kidney failure: Controversy and perspective.
Hypocalcaemia is frequently associated with
hyperphosphataemia in CKD with its mechanism associated with primary hyposecretion of parathormone which results in a progressive decrease in blood calcium levels up to a steady state characterised by an equality between urinary calcium excretion and osseous calcium secretion [13,14].
Phosphorus,
hyperphosphataemia and phosphate binders in chronic kidney disease.
(39.) Cozzolino M, Mazzaferro S, Brandenburg V: The treatment of
hyperphosphataemia in CKD: Calciumbased or calcium-free phosphate binders?
